Your SlideShare is downloading. ×
0
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Vasoconstrictors
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Vasoconstrictors

1,609

Published on

Published in: Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,609
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
76
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Vasoconstrictors Vasoconstrictors are the drugs that constricts the blood vessels and thereby control tissue perfusion. They are added to LA to oppose the vasodilatory action of local anesthetic agent.
  • 2. Classification of Vasoconstrictors Catecholamines Epinephrine Norepinephrine Dopamine Noncatecholamines Amphetamine Methamphetamine Phenylephrine
  • 3.  Direct acting Epinephrine Norepinephrine Dopamine Phenylephrine Indirect acting Tyramine Amphetamine Methamphetamine Mixed acting Metaraminol ephedrine
  • 4.  Receptors β1, β2, β3, alpha receptors Alpha receptors:- blood vessels β 1:- heart and intestine β 2:- bronchi, vascular bed, uterus β3:- brown and white adipose tissue Alpha receptors Activation results in vasoconstriction ( blood vessels)
  • 5. Maximum recommended dose foradrenaline For healthy patients 0.2mg per appointment For cardiac patients 0.04mg per appointment 0.0125mg ---- 1ml 0.2mg----1/0.125x 0.2 = 16ml 1:80,000 = 16 ml in healthy patients 0.0125mg ---- 1ml 0.04mg------1/0.125x0.04 = 3.2ml 1:80,000 = 3.2 ml in cardiac patients
  • 6. Dilution of vasoconstrictors 1:1000  1 gm/1000ml 1000mg/1000ml 1mg/ml 1:10,000 1000mg/10000ml 0.1mg/ml 1:80,000 0.0125mg/ml 1:200,000mg/ml 0.005mg/ml 1:100,000 0.01mg/ml
  • 7. Felypressin (Citanest forte) Available as a vasoconstrictor in combination with prilocaine Acts by directly stimulating vascular smooth muscle Has little effect on heart or on adrenergic nerve trasmission Actions more pronounced on venous than arteriolar microcirculation
  • 8. Epinephrine NorepinephrineReceptor activity Powerful stimulant of α and Stimulates both α and β β receptors receptors, but α effect With higher doses α effects predominates predominates, whereas lower doses primarily produce β receptor activityBlood Pressure (BP) Lesser effect Greater increase in BP than epinephrineCentral Nervous System Greater effect of stimulation Does not stimulate central of central nervous system in nervous system in large doses therapeutic dosesCardiovascular system Greater effect of stimulation of CVSBronchi Dilatation Little or no effectHeart Rate (HR) Increase in HR is of greater Increase in HR is of lesser degree degree
  • 9. Various dilutions available in India and MRD (in terms of m) for normal healthy adult individuals and medically compromised individuals Dilutions Normal adult healthy Medically compromised individuals individuals (0.2 mg/appointment) (0.04 mg/appointment) (ml) (ml) 1:80,000 16 3.2 1:1,00,000 20 4 1:2,00,000 40 8
  • 10.  What determines the potency of LA? Lipid solubility What determines the duration of action of LA? Protein binding e.g. Bupivacaine What determines the onset time of LA? pKa To what components of LA are patients likely to be allergic? Methylparaben Sodium metabisulfite Sulfa drugs(Articaine) latex
  • 11.  What type of LA have greater allergic potential? Esters How are LA metabolized? Esters:- plasma by pseudocholinesterase Amide:-in liver by microsomal enzymes Why is LA often ineffective when injected in area on infection area of inflammation After LA injection anesthetic effect will disappear and re-appear in a definite order. What are the sensation in increasing order of resistance to conduction? Pain < Cold < warm < touch < deep pressure
  • 12. Toxicity The term toxicity, or toxic overdose, refers to the symptoms manifested as the result of overdosage or excessive administration of a drug. This complication depends on a sufficient concentration of the drug in the blood-stream to adversely affect the central nervous system, the respiratory system, or the circulatory system. The blood level necessary to produce a toxic effect may differ for the same drug from individual to individual and in the same individual from day to day.
  • 13. Toxic effects on the central nervous system Although local anesthetics used in dentistry have the ability to produce overt signs and symptoms of central nervous system stimulation, the effect is actually produced by depression of certain inhibitory centers. Depression of inhibitory areas allows excitatory actions to occur unopposed, leading to overt manifestation of central nervous system stimulation.
  • 14.  In subtoxic doses(0.05-4 µg/ml of procaine and lidocaine), local anesthetics may be shown to produce anti-convulsant effects. Epileptic patients exhibit hyper-excitable neurons at the cortical site from which their seizures originate. Subtoxic doses of local anesthetics depress these hyper-excitable neurons, thereby producing an anticonvulsant effect.
  • 15. Cortical stimulationMedullary stimulationCortical depressionMedullary depression
  • 16. Increasing blood levels of local anesthetics (in the range of 4.0 to 7.0 µg/ml) produce definite clinical signs and symptoms by stimulation of cortex. Signs of this degree of toxicity on cortical centers include talkativeness, slurred speech, apprehension, localized muscular twitching tremor of the hands and feet. ringing in the ears (tinnitus), difficulty focusing the eyes disorientation
  • 17.  Medullary stimulation occurs at the dose of 7.5- 10.0 µg/ml which causes generalised tonic clonic seizures by medullary stimulation. In excessive medullary stimulation, cardiovascular and respiratory parameters increase. Usually, respiratory function is totally ineffective during the seizure because of tonic and/or asynchronous contraction of the muscles of respiration.
  • 18.  Following the medullary stimulation, a period of cortical depression occurs. This period is characterized by cortical depression followed by medullary depression. Cortical depression is manifested as Unresponsiveness unconsciousness Stupor coma
  • 19.  Medullary depression results in severe  depression of cardiovascular function respiratory depression hypoxia with its subsequent effect on the cardiac mechanism.
  • 20. Syncope It refers to a sudden, transient loss of consciousness usually secondary to cerebral ischemia due to peripheral pooling of blood and reduced cardiac output. It can be due to; Fright and anxiety Emotional stress Pain of sudden and unexpected nature Sight of blood Non psychogenic :- Hunger or starvation Poor physical condition Overcrowded places
  • 21. Syncope It is the most frequent complication of associated with LA in dental office. It is a form of neurogenic shock and is caused by cerebral ischemia secondary to the vasodilatation with a corresponding drop in blood pressure. It is not always associated with loss of conciousness. It should be treated as early as possible. It is characterised by change in patient’s appearance, such as pallor.
  • 22. Management of syncope Any procedure that is going on should be stopped and the chair should be lowered and legs raised (Trendelburg position) If the patient is conscious, ask for few deep breaths. Keep a check on pulse, respiration, blood pressure
  • 23. CPR Cardiopulmonary resuscitation (CPR) is an emergency procedure for people in cardiac arrest or, in some circumstances, respiratory arrest. CPR is performed both in hospitals and in pre-hospital settings.
  • 24.  CPR involves physical interventions to create artificial circulation through rhythmic pressing on the patients chest to manually pump blood through the heart, called chest compressions, and usually also involves the rescuer exhaling into the patient (or using a device to simulate this) to ventilate the lungs and pass oxygen in to the blood, called artificial respiration
  • 25.  Tilt the head back and listen for breathing. If not breathing normally, pinch nose and cover the mouth with yours and blow until you see the chest rise. Give 2 breaths. Each breath should take 1 second
  • 26.  If the victim is still not breathing normally, coughing or moving, begin chest compressions. Push down on the chest 1½ to 2 inches 30 times. Pump at the rate of 100/minute, faster than once per second.
  • 27. CPR (when one person is doing):Chest cpmpression : artificial respiration 4 : 1CPR (when two persons are doing):Chest cpmpression : artificial respiration 15 : 2

×